CAPTRUST Financial Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-163
Closed -$12K 3801
2022
Q2
$12K Sell
163
-21
-11% -$1.35K ﹤0.01% 3664
2022
Q1
$15K Sell
184
-287
-61% -$21.4K ﹤0.01% 3585
2021
Q4
$43K Sell
471
-421
-47% -$45.2K ﹤0.01% 2776
2021
Q3
$115K Buy
892
+8
+0.9% +$1.12K ﹤0.01% 1959
2021
Q2
$135K Buy
884
+230
+35% +$30.3K ﹤0.01% 1794
2021
Q1
$69K Buy
+654
New +$65.5K ﹤0.01% 2217
2020
Q4
Sell
-1,069
Closed -$60K 3505
2020
Q3
$60K Buy
1,069
+1,000
+1,449% +$53.9K ﹤0.01% 1567
2020
Q2
$4K Buy
+69
New +$2.82K ﹤0.01% 2461
2019
Q4
Sell
-101
Closed -$3K 1696
2019
Q3
$3K Sell
101
-60
-37% -$1.82K ﹤0.01% 1752
2019
Q2
$5K Hold
161
﹤0.01% 1654
2019
Q1
$6K Sell
161
-148
-48% -$5.24K ﹤0.01% 1503
2018
Q4
$10K Hold
309
﹤0.01% 1228
2018
Q3
$15K Hold
309
﹤0.01% 1111
2018
Q2
$10K Buy
+309
New +$7.23K ﹤0.01% 1178

Other funds holding STAA

CAPTRUST Financial Advisors's STAA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 163 shares — an estimated $12K sold.

CAPTRUST Financial Advisors first reported a position in STAA in Q2 2018 and held it in 14 quarters. The position peaked at $135K in Q2 2021. 304 funds tracked by Wall St. Rank hold STAA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 163 STAAR Surgical shares in Q3 2022, an estimated $12K.
  • CAPTRUST Financial Advisors first reported a position in STAAR Surgical in Q2 2018 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's STAAR Surgical position peaked at $135K in Q2 2021.
  • 304 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.